Review of Sourcing Change, Foreign-Trade Subzone 7M, Amgen Manufacturing Limited (Biotechnology and Healthcare Products), Juncos, Puerto Rico, 10884 [E9-5486]
Download as PDF
10884
Federal Register / Vol. 74, No. 48 / Friday, March 13, 2009 / Notices
located at the former Chanute Air Force
Base, 601 S. Century Boulevard,
Rantoul; and, Proposed Site 8 (333
acres) -- Logistics Park Galesburg, 659
Knox Road 1440N (U.S. 150 East and I–
74), Galesburg. The proposal would
result in an overall net increase of 676
acres in total zone space. The proposed
sites will provide warehousing and
distribution services to area businesses.
No specific manufacturing authority is
being requested at this time. Such
requests would be made to the Board on
a case–by-case basis.
In accordance with the Board’s
regulations, Camille Evans of the FTZ
Staff is designated examiner to
investigate the application and report to
the Board.
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at the
address listed below. The closing period
for their receipt is May 12, 2009.
Rebuttal comments in response to
material submitted during the foregoing
period may be submitted during the
subsequent 15-day period (to May 27,
2009).
A copy of the application will be
available for public inspection at the
Office of the Executive Secretary,
Foreign–Trade Zones Board, Room
2111, U.S. Department of Commerce,
1401 Constitution Avenue NW,
Washington, DC 20230–0002, and in the
‘‘Reading Room’’ section of the Board’s
website, which is accessible via
www.trade.gov/ftz. For further
information, contact Camille Evans at
CamillelEvans@ita.doc.gov or (202)
482–2350.
Dated: March 6, 2009.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E9–5484 Filed 3–12–09; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
[Docket 8–2009]
sroberts on PROD1PC70 with NOTICES
Review of Sourcing Change, Foreign–
Trade Subzone 7M, Amgen
Manufacturing Limited (Biotechnology
and Healthcare Products), Juncos,
Puerto Rico
Pursuant to the regulations of the
Foreign–Trade Zones (FTZ) Board (the
Board), a review has been initiated
(under 15 CFR Sec. 400.28(a)(3)(iii)(A))
of changes in sourcing related to certain
packaging products at Foreign–Trade
Subzone 7M, at the facility of Amgen
VerDate Nov<24>2008
17:55 Mar 12, 2009
Jkt 217001
Manufacturing Limited (Amgen), in
Juncos, Puerto Rico.
Subzone 7M was approved by the
Board on December 11, 2008 (Board
Order 1597, 73 FR 78290–78291, 12/22/
08), for the manufacturing and
distribution of biotechnology and
healthcare products under FTZ
procedures. On products shipped to the
U.S. market, the company is able to
choose the duty rate during customs
entry procedures that applies to the
finished products (duty–free) for the
otherwise dutiable foreign components
(duty–free to 2.7%). Components
sourced from abroad include vials,
syringes, stoppers, plunger rods,
partitions and dispenser packs.
Amgen has now notified the Board of
additional sourcing of foreign packaging
components. The imported components
are PVC film (duty rate 5.8%) and a
plastic device to be used with a syringe
in the self–injection process (duty rate,
5.3%). The use of FTZ procedures for
the additional components could
exempt Amgen from customs duty
payments on the foreign components
used in export production. The
company estimates that some 48 percent
of the plant’s shipments are exported.
On its domestic sales, Amgen would be
able to choose the duty rate during
customs entry procedures that applies to
the finished pharmaceutical products
(duty–free) for the foreign inputs noted
above. The finished pharmaceutical
products remain unchanged and were
included in the scope of manufacturing
authority approved by the FTZ Board.
In accordance with the Board’s
regulations, Elizabeth Whiteman is
designated examiner to investigate the
sourcing change, including its potential
to cause ‘‘significant adverse effects’’’
(15 CFR 400.28(a)(3)(iii)(A)), and report
to the Board.Public comment is invited
from interested parties. Submissions
(original and 3 copies) shall be
addressed to the Board’s Executive
Secretary at the address below. The
closing period for their receipt is April
13, 2009. Rebuttal comments in
response to material submitted during
the foregoing period may be submitted
during the subsequent 15-day period to
April 27, 2009.
A copy of the sourcing change
notification will be available for public
inspection at the Office of the Executive
Secretary, Foreign–Trade Zones Board,
Room 2111, U.S. Department of
Commerce, 1401 Constitution Avenue,
NW, Washington, DC 20230–0002, and
in the ‘‘Reading Room’’ section of the
Board’s website, which is accessible via
www.trade.gov/ftz.
For further information, contact
Elizabeth Whiteman at
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
ElizabethlWhiteman@ita.doc.gov or
(202) 482–0473.
Dated: March 5, 2009.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E9–5486 Filed 3–12–09; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–882]
Refined Brown Aluminum Oxide from
the People’s Republic of China: Notice
of Continuation of Antidumping Duty
Order
AGENCY: Import Administration,
International Trade Administration,
Department of Commerce.
SUMMARY: As a result of the
determinations by the Department of
Commerce (the Department) and the
International Trade Commission (ITC)
that revocation of the antidumping duty
order on refined brown aluminum oxide
(RBAO) from the People’s Republic of
China (PRC) would be likely to lead to
continuation or recurrence of dumping
and of material injury to an industry in
the United States within a reasonably
foreseeable time, the Department is
publishing notice of the continuation of
this antidumping duty order.
EFFECTIVE DATE: March 13, 2009.
FOR FURTHER INFORMATION CONTACT:
David Goldberger, Katherine Johnson, or
Brandon Farlander, AD/CVD
Operations, Import Administration,
International Trade Administration,
U.S. Department of Commerce, 14th
Street & Constitution Avenue, NW,
Washington, DC 20230; telephone: (202)
482–4136, (202) 482–4929, and (202)
482–0182, respectively.
SUPPLEMENTARY INFORMATION:
Background
On October 1, 2008, the Department
initiated and the ITC instituted a sunset
review of the antidumping duty order
on RBAO from the PRC, pursuant to
section 751(c) of the Tariff Act of 1930,
as amended (the Act). See Initiation of
Five-year (‘‘Sunset’’) Reviews 73 FR
57055 (October 1, 2008).
The Department conducted an
expedited sunset review of this order.
As a result of its review, the Department
found that revocation of the
antidumping duty order would be likely
to lead to continuation or recurrence of
dumping and notified the ITC of the
magnitude of the margins likely to
prevail were the order to be revoked.
See Refined Brown Aluminum Oxide
E:\FR\FM\13MRN1.SGM
13MRN1
Agencies
[Federal Register Volume 74, Number 48 (Friday, March 13, 2009)]
[Notices]
[Page 10884]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-5486]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket 8-2009]
Review of Sourcing Change, Foreign-Trade Subzone 7M, Amgen
Manufacturing Limited (Biotechnology and Healthcare Products), Juncos,
Puerto Rico
Pursuant to the regulations of the Foreign-Trade Zones (FTZ) Board
(the Board), a review has been initiated (under 15 CFR Sec.
400.28(a)(3)(iii)(A)) of changes in sourcing related to certain
packaging products at Foreign-Trade Subzone 7M, at the facility of
Amgen Manufacturing Limited (Amgen), in Juncos, Puerto Rico.
Subzone 7M was approved by the Board on December 11, 2008 (Board
Order 1597, 73 FR 78290-78291, 12/22/08), for the manufacturing and
distribution of biotechnology and healthcare products under FTZ
procedures. On products shipped to the U.S. market, the company is able
to choose the duty rate during customs entry procedures that applies to
the finished products (duty-free) for the otherwise dutiable foreign
components (duty-free to 2.7%). Components sourced from abroad include
vials, syringes, stoppers, plunger rods, partitions and dispenser
packs.
Amgen has now notified the Board of additional sourcing of foreign
packaging components. The imported components are PVC film (duty rate
5.8%) and a plastic device to be used with a syringe in the self-
injection process (duty rate, 5.3%). The use of FTZ procedures for the
additional components could exempt Amgen from customs duty payments on
the foreign components used in export production. The company estimates
that some 48 percent of the plant's shipments are exported. On its
domestic sales, Amgen would be able to choose the duty rate during
customs entry procedures that applies to the finished pharmaceutical
products (duty-free) for the foreign inputs noted above. The finished
pharmaceutical products remain unchanged and were included in the scope
of manufacturing authority approved by the FTZ Board.
In accordance with the Board's regulations, Elizabeth Whiteman is
designated examiner to investigate the sourcing change, including its
potential to cause ``significant adverse effects''' (15 CFR
400.28(a)(3)(iii)(A)), and report to the Board.Public comment is
invited from interested parties. Submissions (original and 3 copies)
shall be addressed to the Board's Executive Secretary at the address
below. The closing period for their receipt is April 13, 2009. Rebuttal
comments in response to material submitted during the foregoing period
may be submitted during the subsequent 15-day period to April 27, 2009.
A copy of the sourcing change notification will be available for
public inspection at the Office of the Executive Secretary, Foreign-
Trade Zones Board, Room 2111, U.S. Department of Commerce, 1401
Constitution Avenue, NW, Washington, DC 20230-0002, and in the
``Reading Room'' section of the Board's website, which is accessible
via www.trade.gov/ftz.
For further information, contact Elizabeth Whiteman at Elizabeth_
Whiteman@ita.doc.gov or (202) 482-0473.
Dated: March 5, 2009.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E9-5486 Filed 3-12-09; 8:45 am]
BILLING CODE 3510-DS-S